Wound Care Graft Products with 6-Year Claims Protection — The Only Triple-Verified Graft Program
We are the only authorized wound care graft supplier that verifies provider credentials, manufacturer compliance, and patient insurance before every shipment — then backs every enrolled account with 6-Year Claims Protection.
Start Your Enrollment Today
Join wound care providers who have eliminated graft claim denials with our triple-verified program.
What Are Wound Care Graft Products?
Everything providers need to know — clinical science, Medicare coverage, and why product selection directly affects your revenue cycle.
Types of Wound Care Graft Products Covered by Medicare Part B
🔬 Amniotic Membrane Allografts
Derived from donated placental tissue. Contains 300+ regulatory proteins promoting tissue regeneration. Available dehydrated or cryopreserved. DermaBind TL and FM are amniotic membrane allografts.
🧬 Acellular Dermal Matrices
Processed human, porcine, or bovine dermis providing structural scaffolding for cellular infiltration. Examples: DermACELL, AlloPatch, SomaGen.
🧪 Placental Membrane Allografts
Multi-layer products from amniotic and chorionic placental layers. Examples: AmnioBand, NuShield, Affinity. May retain living cellular components.
⚗️ Tissue-Engineered Substitutes
Bioengineered products with living cells and scaffolding — such as Apligraf — designed to transform chronic wound environments to an acute healing state.
How Amniotic Wound Care Grafts Promote Healing
Growth factors, cytokines, and ECM components that stimulate cell migration and new tissue formation
Natural bacteriostatic properties reduce infection risk without synthetic antibiotics
Reduces chronic inflammation that stalls healing — transforms wound to acute healing state
Clinical trials demonstrate significantly accelerated closure versus standard-of-care dressings alone
Are Wound Care Graft Products Covered by Medicare?
Yes. Medicare Part B covers amniotic wound care grafts and skin substitute products under CPT codes 15271–15278 and associated Q-codes, subject to Local Coverage Determinations (LCDs). Coverage requires documented medical necessity, wound chronicity, and failure of prior standard-of-care therapy. Our 3-Step IVR process confirms Medicare coverage for your specific patient before every application. See our complete Medicare wound care billing guide →
Graft Claims Are the #1 Revenue Risk in Wound Care — Here Is How We Eliminate It
Amniotic membrane grafts represent some of the highest-reimbursement procedures in wound care — and some of the highest claim denial and audit risk. Three root causes account for nearly all graft claim failures.
Provider Credential Failures
Providers apply graft products before confirming their Medicare enrollment status for that specific procedure type. Payers deny entire claim histories retroactively when credential gaps are discovered — sometimes years later.
Product Documentation Gaps
Incorrect Q-codes, missing NDC numbers, or product chain-of-custody failures are among the top three causes of graft claim denial and Medicare RAC audit flags — often surfacing years after the date of service.
Insurance Coverage Surprises
LCD policies for wound care grafts vary by MAC jurisdiction and change periodically. Providers who apply grafts without verifying payer-specific coverage frequently face denials they could not anticipate — until it is too late.
Medicare RAC Audits Can Look Back for Years
Medicare’s Recovery Audit Contractors have broad authority to review and recoup graft-related claim payments going back multiple years. Providers have faced six-figure recoupment demands long after the procedures were performed — because their graft supplier offered no documentation protection. Most wound care graft suppliers offer zero audit protection. We built the only program that does.
Our 3-Step IVR Process: Verify Everything Before Every Shipment
IVR stands for Integrated Verification and Reimbursement. Before your first DermaBind shipment — and before every subsequent application — we run three independent verifications that eliminate the three root causes of graft claim denial. No other wound care graft supplier in the United States does this.
Step 1 — Provider Verified
We confirm your practice’s Medicare enrollment status, specialty credentialing, and eligibility to bill for skin substitute and cellular/tissue-based product procedures before your first order is placed.
- Medicare Part B enrollment confirmed
- NPI and PTAN verified for wound care procedures
- Specialty credential review against payer policies
- Any gaps identified and resolved before shipment
Step 2 — Manufacturer Verified
Every DermaBind product ships with complete NovaMed FDA regulatory documentation. We pre-load the correct Q-codes and NDC numbers for your billing system, ensuring clean claim submission from day one.
- FDA HCT/P regulatory documentation confirmed
- Correct Q-code identified for your specific product
- NDC number pre-loaded in your billing file
- Full chain-of-custody documentation provided
Step 3 — Insurance Verified
Before every graft application, we run patient-specific eligibility and coverage verification against the applicable Local Coverage Determination (LCD) for your MAC jurisdiction. You know before the procedure — not after.
- Patient-specific Medicare eligibility confirmed
- LCD policy coverage verified for your MAC zone
- Prior authorization status checked where required
- Coverage confirmation provided before application
6-Year Claims Protection: A Promise No Other Supplier Makes
Triple verification dramatically reduces your denial risk upfront. But we go further. Every enrolled practice receives 6-Year Claims Protection — a level of security that does not exist anywhere else in the wound care graft market.
Most graft suppliers hand you a product and walk away. If your claim is denied six months later, or if a Medicare auditor comes knocking three years after the procedure, you are on your own — the documentation burden, the appeal process, the potential recoupment.
Our 6-Year Claims Protection changes that entirely. For every claim processed through our verified program, we provide active support if that claim is challenged within six years of the service date.
- Active appeal support if a verified claim is denied within 6 years
- Full documentation package ready for any audit request
- RAC audit response assistance for all enrolled accounts
- No additional cost — included with enrollment
- Applies to DermaBind TL and FM product lines
- Protects against retroactive Medicare recoupment on verified claims
Protection Included with every
verified enrollment
DermaBind TL & FM: Amniotic Wound Care Grafts with Full Billing Support
DermaBind products are human amniotic membrane allografts distributed by NovaMed Group, LLC. Both products are covered under Medicare Part B and enrolled through our triple-verified program. Every enrolled account receives complete billing and coding support.
DermaBind TL
True Layer — Single-membrane amniotic allograft for standard chronic wound applications
Clinical Indications
DermaBind FM
Full Membrane — Multi-layer amniotic graft for complex wounds requiring enhanced structural support
Clinical Indications
Elite Med Financials vs. Standard Graft Suppliers
Most wound care graft suppliers provide a product and a product sheet. We provide a complete verified wound care revenue program. See the difference.
| Feature | Elite Med Financials | Standard Graft Supplier |
|---|---|---|
| Medicare-covered amniotic graft products | ✓ Yes (DermaBind TL & FM) | ✓ Yes (varies) |
| Provider credential verification before shipment | ✓ Step 1 — Always | ✗ Not offered |
| Manufacturer FDA documentation pre-loaded | ✓ Step 2 — Every order | ✗ Provider responsibility |
| Patient-specific insurance verification | ✓ Step 3 — Every application | ✗ Not offered |
| Claims protection period | ✓ 6 Years | ✗ None |
| RAC audit appeal support | ✓ Included | ✗ Not offered |
| Wound care billing services available | ✓ Full RCM services | ✗ Not offered |
| Single-source for products + billing | ✓ Unique to Elite Med | ✗ Not available |
How to Enroll Your Practice — 4 Easy Steps
From first contact to your first verified DermaBind shipment, most practices complete enrollment within 5–7 business days. We handle every step of the verification process.
Request Your Enrollment Packet
Contact our graft enrollment team using the form below or by phone. We send you the DermaBind Enrollment & Claims Protection Guide — a complete overview of the program, the 3-step verification process, the 6-Year Claims Protection terms, and what we need from your practice to begin.
⏱ 24-hour response guaranteedStep 1 & 2 Verification — Provider and Manufacturer
Our team runs your provider credential verification (Step 1) and pre-loads the correct DermaBind product documentation, Q-codes, and NDC numbers for your billing system (Step 2). We notify you of your verification status and resolve any gaps before your first order.
⏱ 3–5 business daysStep 3 Verification — Insurance Coverage Confirmed Per Patient
Before your first graft application — and every subsequent one — we run Step 3: patient-specific Medicare eligibility, LCD policy coverage, and prior authorization status. You receive confirmation before the product is applied. If a coverage risk exists, you know in advance — never after.
⏱ 1–2 business days per patientFirst Verified Shipment — 6-Year Protection Active
DermaBind ships with full documentation. Your account is enrolled in 6-Year Claims Protection from your first verified application date. If you also use our wound care billing services, we manage the complete claim submission, denial management, and payment posting cycle on your behalf.
⏱ First shipment within 5–7 business days of enrollmentWhy Elite Med Financials Is Different from Every Other Graft Supplier
We are not just a graft supplier. We are the only company in the wound care market that both supplies Medicare-covered graft products AND manages complete wound care billing and revenue cycle services.
Triple-Verified Before Every Shipment
No other graft supplier verifies all three factors — provider, manufacturer, and insurance — before every order. We built this process specifically to protect provider revenue.
6-Year Claims Protection
The Medicare audit window is real. Our 6-Year Claims Protection is the only graft-specific claims defense program in the market — included at no extra cost with every enrolled account.
Authorized DermaBind Representative
We are an authorized NovaMed Group representative for DermaBind — amniotic membrane allografts with full FDA documentation and Medicare Part B coverage. Compliant product, verified program.
Complete Wound Care Billing Services
Enrolled practices access our full wound care billing and RCM services — trusted by wound care providers nationwide. One partner for your product supply and your revenue cycle.
Single-Source Revenue Accountability
When your graft supplier and billing partner are the same company, there is no finger-pointing when a claim is denied. We are accountable for every step — from verification to payment.
HIPAA Certified Throughout
All Elite Med Financials representatives maintain current HIPAA certification. Our verification and billing processes are fully compliant with Medicare and all federal program requirements.
Common Wound Care Graft Questions Answered
What wound care providers ask most before enrolling — from clinical selection to Medicare coverage to billing codes.
What dressing is used over a wound care graft?
A moist, non-adherent primary dressing is placed directly over amniotic grafts like DermaBind to maintain wound moisture and prevent mechanical disruption. A secondary absorbent layer follows, then a secure wrap. Dressing selection should match exudate volume — petrolatum-based non-adherents for low-exudate, foam or alginate secondaries for higher output wounds.
How do I choose the right wound graft product for my patients?
Product selection should consider wound type and etiology (diabetic foot ulcer, venous leg ulcer, pressure injury each have specific LCD requirements), wound size and depth, exudate levels, and — critically — payer coverage for that specific product’s Q-code. Our Step 3 verification confirms Q-code coverage before application for all enrolled accounts.
What is the difference between dehydrated and cryopreserved amniotic grafts?
Dehydrated amniotic membrane (DermaBind TL) is shelf-stable at room temperature with a long shelf life, easy to store, and retains ECM and growth factors. Cryopreserved products retain a higher percentage of living cells but require cold-chain storage. Both types are Medicare Part B covered when correctly documented and billed with the appropriate Q-code.
How many graft applications does Medicare cover?
Medicare LCD policies set frequency limitations based on wound type, measurable healing response, and ongoing medical necessity documentation. Repeat applications are covered when the wound shows measurable response but has not closed. Providers must document wound measurements at each visit. Our Step 3 verification confirms payer-specific frequency limits before each application.
Which wound types respond best to amniotic membrane grafts?
Primary indications: diabetic neuropathic foot ulcers (highest RCT evidence base), venous leg ulcers (strong Medicare coverage rate), pressure injuries Stage II–IV with failed standard care, post-surgical wounds with delayed healing, and selected traumatic wounds. Contraindications include clinically infected wounds and undocumented treatment failure.
What documentation is required to bill wound graft procedures?
Required: wound measurement at each visit, documented chronicity (30+ days without healing), prior standard-of-care treatment failure, medical necessity narrative, product name and Q-code, total surface area applied, product chain-of-custody from supplier, and signed informed consent. Our Step 2 pre-loads product documentation and our billing team ensures all clinical notes meet payer requirements. See complete billing codes →
Wound Care Billing Resources for Enrolled Practices
The only graft supplier whose billing knowledge library covers every CPT code, LCD policy, and RCM strategy your practice needs.
Wound Care Graft Products — FAQ
Everything providers ask before enrolling in our verified graft program — answered directly.
Yes. DermaBind TL and DermaBind FM are amniotic membrane allografts covered under Medicare Part B for diabetic foot ulcers, venous leg ulcers, and pressure injuries, subject to Local Coverage Determinations (LCDs). Our 3-Step IVR process confirms your specific payer and patient coverage before every application — eliminating coverage surprises. Read our Medicare wound care billing guide →
IVR stands for Integrated Verification and Reimbursement. Step 1 (Provider Verified) confirms your practice’s Medicare enrollment and credentialing. Step 2 (Manufacturer Verified) confirms NovaMed’s FDA documentation and pre-loads the correct Q-code and NDC number. Step 3 (Insurance Verified) confirms patient-specific eligibility, LCD coverage, and prior authorization before every application — eliminating the three root causes of graft claim denial.
Medicare RAC auditors have authority to review graft claims going back multiple years. For every verified claim processed through our program, we provide active support if that claim is challenged within 6 years — including appeal preparation, documentation assembly, and RAC audit response assistance at no additional cost. This protection is exclusive to Elite Med Financials and included with every enrolled account.
Denial rates on verified claims are significantly lower than industry average. However, if a denial occurs on a verified claim, our billing specialists initiate the appeal process immediately under our 6-Year Claims Protection. For practices using our wound care billing services, we manage the complete denial and appeals workflow. Learn about our denial management services →
Yes — and this is what makes Elite Med Financials unique. We are the only company that both supplies Medicare-covered wound care graft products AND provides complete wound care billing and RCM services. Enrolled practices get a single point of accountability for product supply, verification, claim submission, denial management, and payment posting. See our complete wound care RCM services →
CPT codes 15271–15278 apply based on wound location and total surface area. The applicable Q-code is product-specific and pre-loaded during our Step 2 manufacturer verification. Common ICD-10 codes include L97.xxx (chronic lower limb ulcers), E11.621 (Type 2 diabetes with foot ulcer), and I83.xxx (varicose veins with ulcer). Our billing team provides complete coding support for all enrolled practices. See our complete wound care billing codes guide →
DermaBind TL (True Layer) is a single-layer dehydrated amniotic membrane for standard chronic wounds — appropriate for most diabetic foot ulcers, venous leg ulcers, and pressure injuries. DermaBind FM (Full Membrane) is a multi-layer product providing enhanced barrier protection and structural support for more complex wounds or larger surface areas. Both are Medicare Part B covered and enrolled through our 3-Step IVR program.
Start with Triple-Verified Claims from Day One
Join wound care providers who have eliminated graft claim denials and RAC audit risk. Fill out the form and our graft enrollment team will send your DermaBind Enrollment & Claims Protection Guide within 24 hours.
Enroll Your Practice
Request your DermaBind Enrollment & Claims Protection Guide
Enrollment Request Received!
Thank you. Our graft enrollment team will contact you within 24 hours with your DermaBind Enrollment & Claims Protection Guide.